AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2020
Jun 19, 2020
35106_dirs_2020-06-19_2b331a14-4ea8-4c3c-a65d-19946a12cce5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2020-06-17
Reporting Person: Schwartz Carl I. (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-17 | Common Stock | A | 4070 | — | Acquired | 1611981 | Direct |
Footnotes
F1: Director stock grant.
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1